Results
1
Stocks with a market cap under US$50M.
1 companies
MindMaze Therapeutics Holding
Market Cap: CHF 34.8m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.23
7D
-3.4%
1Y
n/a
